We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $1.67B
1-Year Est. Return 7.53%
This Fund
S&P 500
This Quarter Est. Return
+37.21%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
–
AUM
$12.6B
AUM Growth
-$623M
Cap. Flow
-$2.3B
Cap. Flow %
-18.28%
Top 10 Hldgs %
64.34%
Holding
108
New
19
Increased
9
Reduced
15
Closed
13

Top Buys

Rank Stock Value
1
DASH icon
DoorDash
DASH
+$137M
2
KOD icon
Kodiak Sciences
KOD
+$129M
3
YQ
17 Education & Technology Group
YQ
+$67.2M
4
ROOT icon
Root
ROOT
+$47.7M
5
SE icon
Sea Limited
SE
+$44.5M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$1.19B
2
ZM icon
Zoom
ZM
+$905M
3
UBER icon
Uber
UBER
+$339M
4
JD icon
JD.com
JD
+$202M
5
ALGN icon
Align Technology
ALGN
+$95.7M

Sector Composition

Rank Sector Weight
1 Healthcare 31.81%
2 Consumer Discretionary 26.55%
3 Technology 18.53%
4 Communication Services 8.53%
5 Consumer Staples 4.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HTHT icon
51
Huazhu Hotels Group
HTHT
$13.3B
$25.1M 0.2%
557,102
+428,316
+333% +$19.5M
ABCL icon
52
AbCellera Biologics
ABCL
$1.65B
$24.1M 0.19%
+600,000
New +$27.4M
EIDX
53
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$23.5M 0.19%
178,600
– –
BEDU
54
DELISTED
Bright Scholar Education Holdings
BEDU
$23M 0.18%
996,449
– –
MOGU
55
MOGU Inc
MOGU
$16.4M
$22.7M 0.18%
870,581
– –
KURA icon
56
Kura Oncology
KURA
$793M
$21.2M 0.17%
+650,000
New +$22.8M
RGNX icon
57
Regenxbio
RGNX
$616M
$20.7M 0.16%
456,000
– –
ALLO icon
58
Allogene Therapeutics
ALLO
$625M
$20.2M 0.16%
800,000
– –
KRON
59
DELISTED
Kronos Bio
KRON
$19.7M 0.16%
+658,436
New +$20.7M
LEGN icon
60
Legend Biotech
LEGN
$3.65B
$18.3M 0.15%
650,000
– –
CELL
61
DELISTED
PhenomeX Inc. Common Stock
CELL
$17.9M 0.14%
200,000
– –
ACMR icon
62
ACM Research
ACMR
$4.51B
$17.4M 0.14%
642,237
+291,714
+83% +$7.46M
RCUS icon
63
Arcus Biosciences
RCUS
$3.33B
$16.2M 0.13%
625,000
– –
ADCT icon
64
ADC Therapeutics
ADCT
$140M
$16M 0.13%
500,000
– –
IGMS
65
DELISTED
IGM Biosciences
IGMS
$13.4M 0.11%
151,390
-198,610
-57% -$14M
SOHU
66
Sohu.com
SOHU
$352M
$12.8M 0.1%
802,034
– –
DYN icon
67
Dyne Therapeutics
DYN
$4.15B
$12.6M 0.1%
600,000
– –
GRUB
68
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$12.6M 0.1%
84,693
– –
CDAK
69
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$11.8M 0.09%
+366,721
New +$4.85M
COGT icon
70
Cogent Biosciences
COGT
$6.76B
$11.2M 0.09%
+1,000,000
New +$11M
RNAM
71
DELISTED
Avidity Biosciences
RNAM
$10.8M 0.09%
425,000
– –
MREO
72
Mereo BioPharma
MREO
$48.9M
$10.7M 0.08%
2,976,121
+1,377,936
+86% +$3.45M
TXG icon
73
10x Genomics
TXG
$5.88B
$10.6M 0.08%
75,000
– –
MRUS
74
DELISTED
Merus
MRUS
$10.5M 0.08%
600,000
– –
HOOK
75
DELISTED
HOOKIPA Pharma
HOOK
$10.5M 0.08%
94,325
– –
1 2
3
4 5

Similar funds

TFS
Thoroughbred Financial Services Brentwood, Tennessee $1.67B AUM 37.77% 1-Year Est. Return
GC
Garde Capital Seattle, Washington $1.67B AUM 13.9% 1-Year Est. Return
PA
Proem Advisors Dallas, Texas $1.68B AUM 199.97% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
NRI
NFP Retirement Inc Aliso Viejo, California $1.67B AUM 13.03% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return

HHLR Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, HHLR Advisors held 108 positions worth $12.6B, down 4.7% from $13.2B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

HHLR Advisors withdrew a net $2.3B in Q4 2020, closing 13 positions and reducing 15 holdings. Its most notable exit was Alibaba, an estimated $1.19B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, HHLR Advisors opened a new position in DoorDash worth $123M.

  • HHLR Advisors's largest Q4 2020 buy was DoorDash: 858,500 shares worth $123M.
  • HHLR Advisors added most to Sea Limited in Q4 2020, an estimated $44.5M increase.
  • HHLR Advisors's biggest Q4 2020 reduction was Zoom, cutting an estimated $905M.
  • HHLR Advisors fully exited Alibaba in Q4 2020, selling an estimated $1.19B.
  • HHLR Advisors's ten largest holdings make up 64% of its $12.6B portfolio in Q4 2020.
  • HHLR Advisors opened 19 new positions and closed 13 in Q4 2020.
  • HHLR Advisors's portfolio value fell 4.7% quarter-over-quarter to $12.6B.

Based on HHLR Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.